(Q40019991)

16 September 2017

The activation of liver glycogen phosphorylase by angiotensin II (English)

1 reference

https://api.crossref.org/works/10.1016/0014-5793(76)80453-X

26 December 2022

1 reference

https://api.crossref.org/works/10.1016/0014-5793(76)80453-X

26 December 2022

1 reference

https://api.crossref.org/works/10.1016/0014-5793(76)80453-X

26 December 2022

1 reference

https://api.crossref.org/works/10.1016/0014-5793(76)80453-X

26 December 2022

1 reference

https://api.crossref.org/works/10.1016/0014-5793(76)80453-X

26 December 2022

1 reference

https://api.crossref.org/works/10.1016/0014-5793(76)80453-X

26 December 2022

author name string

S. Keppens

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A185090

26 December 2022

H. De Wulf

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A185090

26 December 2022

language of work or name

English

0 references

publication date

1 October 1976

1 reference

full work available at URL

16 September 2017

http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1016%2F0014-5793%2876%2980453-X

1 reference

https://api.crossref.org/works/10.1016/0014-5793(76)80453-X

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1016%2F0014-5793(76)80453-X

26 December 2022

1 reference

https://api.crossref.org/works/10.1016/0014-5793(76)80453-X

https://onlinelibrary.wiley.com/doi/full/10.1016/0014-5793(76)80453-X

26 December 2022

1 reference

https://api.crossref.org/works/10.1016/0014-5793(76)80453-X

26 December 2022

1 reference

16 September 2017

68

1 reference

16 September 2017

279-282

1 reference

16 September 2017

2

1 reference

Stimulation by vasopressin of glycogen breakdown and gluconeogenesis in the perfused rat liver

16 September 2017

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2876%2980453-X

Inhibition of fatty acid synthesis and stimulation of glycogen breakdown by vasopressin in the perfused mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2876%2980453-X

The activation of liver glycogen phosphorylase by vasopressin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2876%2980453-X

The renin-angiotensin system (first of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2876%2980453-X

21 January 2018

Renin-Angiotensin System

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2876%2980453-X

Effects of synthetic angiotensin on plasma free fatty acid and blood glucose-levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2876%2980453-X

Profile of circulating vasoactive substances in hemorrhagic shock and their pharmacologic manipulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2876%2980453-X

Metabolic actions of vasopressin, glucagon and adrenalin in the intact rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2876%2980453-X

Hepatic action of vasopressin: lack of a role for adenosine-3',5'-cyclic monophosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2876%2980453-X

Hemodynamic and metabolic effects of angiotensin II during rest and exercise in normal healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2876%2980453-X

EFFECT OF ANGIOTENSIN 11 ON BLOOD GLUCOSE LEVEL IN THE DOG

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2876%2980453-X

The sequential inactivation of glycogen phosphorylase and activation of glycogen synthetase in liver after the administration of glucose to mice and rats. The mechanism of the hepatic threshold to glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2876%2980453-X

The activation of liver phosphorylase b kinase by glucagon

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2876%2980453-X

A new, long-lasting competitive inhibitor of angiotensin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2876%2980453-X

The effects of alteration of blood-volume on the concentration of circulating angiotensin in anaesthetized dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2876%2980453-X

Metabolic effects of angiotensin.

21 January 2018

13

1 reference

https://api.crossref.org/works/10.1016/0014-5793(76)80453-X

Archives internationales de physiologie et de biochimie

26 December 2022

15

83

375

Keppens

1975

1 reference

https://api.crossref.org/works/10.1016/0014-5793(76)80453-X

Archives internationales de physiologie et de biochimie

26 December 2022

16

84

167

Keppens

1976

1 reference

https://api.crossref.org/works/10.1016/0014-5793(76)80453-X

Angiotensin blood levels in hypovolemic shock during osmotic diuresis

26 December 2022

21

1 reference

https://api.crossref.org/works/10.1016/0014-5793(76)80453-X

ANGIOTENSIN BLOOD LEVELS IN HEMORRHAGIC HYPOTENSION AND OTHER RELATED CONDITIONS

26 December 2022

22

1 reference

https://api.crossref.org/works/10.1016/0014-5793(76)80453-X

Changes in catecholamine and angiotensin levels in the cat and dog during hemorrhage

26 December 2022

23

1 reference

https://api.crossref.org/works/10.1016/0014-5793(76)80453-X

26 December 2022

Identifiers

1 reference

16 September 2017

1 reference